GVHD and the Cornea: What Transplant Patients Need to Know
How GVHD Affects the Eye
GVHD can cause a range of eye problems, from persistent dryness to serious corneal damage. Understanding how and why the eye becomes involved helps patients recognize symptoms early and seek the right care before problems worsen.
GVHD occurs when transplanted donor cells treat the recipient's body as a threat and launch an immune attack on healthy tissue. The eye is a common site for this attack because its surface and tear-producing glands contain a high concentration of immune cells. Without early intervention, ongoing inflammation can damage the cornea and reduce vision.
- Severe dry eye caused by damage to the tear-producing glands
- Corneal surface breakdown and slow healing
- Scarring of the inner eyelid lining, called the conjunctiva
- Corneal thinning in advanced cases
GVHD takes two forms. Acute GVHD develops within the first weeks or months after a transplant and most often affects the skin, digestive tract, and liver. Chronic GVHD develops later and can persist for years, and the eye is one of its most frequent targets. While both forms can affect the cornea, chronic GVHD is the more common cause of lasting eye damage.
The lacrimal glands, which produce the watery layer of tears, are packed with immune cells and are often targeted early in GVHD. As donor cells attack these glands, they become scarred and produce less fluid over time. When the tear film thins, the surface of the eye dries out, becomes fragile, heals more slowly, and grows more vulnerable to infection and injury.
Not every transplant patient will develop eye GVHD, but certain factors raise the likelihood. If you have any of these risk factors, it is worth discussing a proactive eye screening plan with your transplant team as early as possible.
- A mismatched or unrelated donor
- Female patient who received a transplant from a male donor
- History of acute GVHD
- Total body radiation before the transplant
- Active chronic GVHD in other organs
- Older age at the time of transplant
Recognizing the Signs of Eye GVHD
Eye GVHD can develop gradually, and its early signs are easy to overlook or dismiss as minor irritation. Knowing what to watch for, and when to seek urgent care, helps protect the cornea before serious damage occurs.
Severe dry eye is the most common eye sign of chronic GVHD. The eye may feel gritty or sandy, burn persistently, and water excessively in response to irritation. Vision often blurs later in the day. Over-the-counter artificial tears may provide brief relief, but they rarely control GVHD-related dryness on their own.
When the eye surface stays dry for extended periods, tiny areas of damage begin to appear across the cornea. These spots, which a cornea specialist can see clearly during a slit lamp examination, most often heal with treatment. If left unaddressed, however, they can develop into open corneal sores that take much longer to resolve. Routine eye exams are essential even when symptoms feel manageable.
GVHD can scar the conjunctiva, the thin tissue lining the inner surface of the eyelids. The lid margins may thicken and roughen, and the meibomian glands, which produce the oily layer of the tear film, can become clogged. Together, these changes compound dry eye and make it harder to keep the corneal surface adequately moist.
In severe cases, persistent dryness and inflammation can lead to a corneal ulcer, an open sore on the cornea, and eventually cause the corneal tissue to thin. A cornea that becomes too thin can rupture, which is a vision-threatening emergency. Any new eye redness combined with pain in a GVHD patient requires same-day evaluation. Do not wait to see if it improves on its own.
Certain symptoms should never wait for a routine appointment. Contact a cornea specialist the same day if you experience any of the following.
- Sudden or sharp eye pain
- A new white or gray spot on the cornea
- Sudden blurred or lost vision
- Sensitivity to light that comes on suddenly
- A very red, hot eye with thick discharge
Transplant patients often have weakened immune systems, which means eye infections can spread rapidly. Prompt care is critical.
How Eye GVHD Is Diagnosed
Diagnosing eye GVHD involves more than asking about symptoms. A full evaluation combines a careful exam with specific tests that reveal what is happening in the tear film and across the corneal surface, and this information guides treatment decisions directly.
A slit lamp is a specialized microscope that shines a precise beam of light into the eye and allows a cornea specialist to examine each layer of the cornea in detail. Dyes, including fluorescein and rose bengal, highlight surface damage that would otherwise be invisible. The exam is painless, takes only a few minutes, and provides essential information about the health of the corneal surface.
Several simple, in-office tests measure how well the tear glands are functioning. A small paper strip placed briefly under the lower eyelid, called a Schirmer test, measures fluid production. A dye-based test called the tear breakup time test shows how quickly the tear film becomes unstable between blinks. Low scores on these tests, combined with symptoms, help confirm a diagnosis of eye GVHD.
When deeper evaluation is needed, additional tools provide a more complete picture. Pachymetry measures the thickness of the cornea to detect dangerous thinning. Optical coherence tomography, known as OCT, maps individual corneal layers in detail. Serial photographs track changes over time and help the care team decide when to escalate treatment.
Eye GVHD is not an isolated problem. A cornea specialist will communicate directly with your transplant team after each visit, sharing findings that may influence how your body-wide GVHD medications are adjusted. This coordinated approach prevents treatments from working against each other and gives you the most complete possible care.
Treatment Options for Eye GVHD
Treatment for eye GVHD is tailored to each patient based on how severe the involvement is and how other organs are responding. Most patients work through a stepwise plan that begins with daily supportive care and advances to more targeted interventions as needed.
The foundation of eye GVHD care begins at home. Preservative-free artificial tears are used multiple times throughout the day to keep the surface moist. Preservative-free formulas are important because eyes that need frequent drops can react to the preservatives found in standard artificial tear products. A lubricating gel or ointment at bedtime extends moisture through the night.
- Preservative-free artificial tears throughout the day
- Lubricating gel or ointment at bedtime
- Warm compresses to help clear clogged lid glands
- Daily lid cleaning to remove debris along the lid margins
- A bedroom humidifier to reduce overnight drying
When supportive care alone does not control symptoms, prescription drops are added. Cyclosporine and lifitegrast eye drops reduce the immune-driven inflammation damaging the tear glands. Short courses of steroid drops can help bring a flare under control more quickly. Punctal plugs, tiny devices placed in the tear drainage openings of the eyelids, help retain whatever moisture the glands can still produce. Many patients use a combination of these therapies together.
For patients with severe eye GVHD, two additional tools have significantly changed outcomes. Autologous serum eye drops are prepared from a small sample of the patient's own blood. They contain natural growth factors and healing proteins that support corneal repair in ways that artificial drops cannot replicate. Scleral lenses are large, custom-fitted rigid contact lenses that arch over the entire cornea and rest on the white of the eye, creating a reservoir of fluid that keeps the corneal surface continuously bathed throughout the day. Both options require coordination with a cornea specialist experienced in their use.
The systemic medications used to suppress GVHD throughout the body, including immunosuppressants and steroids, directly affect eye disease as well. When eye signs flare, your transplant team may adjust these medications in ways that also help the cornea. It is important never to change or stop any systemic medication on your own. Every adjustment should be made collaboratively by the full care team, with input from both your cornea specialist and your transplant physician.
When other measures are not enough to protect the cornea, procedural options are available. A bandage contact lens can cover and shield damaged corneal tissue while it heals. An amniotic membrane, a thin biological graft derived from placental tissue, promotes healing of deep corneal damage. In patients whose eyelids cannot close fully and leave the cornea exposed, a procedure called tarsorrhaphy partially closes the eyelids to protect the surface. Corneal transplantation remains a last-resort option for cases where the cornea has sustained irreversible damage despite all other interventions.
Living Well With Eye GVHD
Managing eye GVHD is an ongoing process, not a one-time treatment. Consistent daily habits, regular exams, and clear communication with your care team make a meaningful difference in long-term outcomes.
Simple choices throughout the day help reduce the burden on your eyes. Staying well hydrated, eating foods rich in omega-3 fatty acids, and avoiding smoke and dry indoor air all support the tear film. Taking regular breaks from screens, using a humidifier in your bedroom, and wearing wraparound sunglasses outdoors to block wind and reduce evaporation can each bring meaningful daily relief.
Most patients who have had a transplant should have a dedicated eye exam every three to six months, even when symptoms feel mild or stable. After any change in your systemic medications or a new flare elsewhere in the body, scheduling an eye visit within a few weeks is advisable. Patients with active corneal disease may need monthly visits while the situation is being brought under control. Staying on schedule allows small changes to be caught and corrected before they become serious.
The best outcomes happen when your eye care team and transplant team work from the same information. Keeping a simple log of your eye symptoms, the drops you use, and any flares you notice gives both teams valuable detail. Bring your log to every appointment and ask your cornea specialist to send notes directly to your transplant physician after each visit. This kind of coordinated communication reduces the chance of any important detail being missed on either side.
Frequently Asked Questions
These answers address the practical questions that come up most often once a diagnosis of eye GVHD has been made or is being considered.
Acute GVHD can cause early eye symptoms within weeks of a transplant, though the eye is less commonly involved in the acute phase than the skin or digestive system. Chronic GVHD of the eye most often develops months to years after transplant and may appear even if the acute phase was mild or well-controlled. Because early dry eye can be subtle and easy to dismiss, a baseline cornea exam in the first few months after transplant establishes a reference point that makes future changes easier to detect.
Eye GVHD tends to be a long-term condition for many patients, rather than something that clears up on its own. Some patients do see meaningful improvement as their systemic GVHD quiets down, and treatment adjustments can lead to periods of better control. Others manage ongoing dry eye and surface fragility with drops and scleral lenses for years. The goal of care is to protect the cornea and preserve functional vision, even when some level of dryness persists. The earlier care begins, the more corneal tissue can be protected over the long term.
Redness-relief drops, sometimes labeled as 'get the red out' products, work by constricting blood vessels in the eye. They do not treat the underlying dryness and can cause a rebound effect that actually makes redness and irritation worse over time. For GVHD patients who need drops frequently throughout the day, preservative-free artificial tears are the appropriate choice. Always check with your cornea specialist before starting any new eye product, since some over-the-counter options can interfere with prescription drops you may already be using.
Unlike standard soft contact lenses, which lie directly on the corneal surface and can add friction to an already irritated eye, scleral lenses vault completely over the cornea and rest on the less sensitive white of the eye, the sclera. This creates a liquid-filled space between the lens and the cornea that keeps the surface continuously bathed in fluid throughout the day. For patients with severe GVHD dry eye, this sustained hydration is often far more comfortable than anything soft lenses or drops alone can provide. Fitting scleral lenses requires specialized expertise, and our optometry team has extensive experience fitting these lenses for patients with corneal disease.
Many patients with eye GVHD continue driving and working, particularly with the right combination of drops, protective eyewear, and workplace adjustments such as screen breaks and reduced glare lighting. Whether driving is safe depends on how well vision is being controlled, and your cornea specialist can advise you based on your current visual function. If you notice that your vision is fluctuating significantly during the day, or that dryness is affecting your ability to see clearly at distance, bring this up at your next appointment so your care plan can be adjusted.
Improved eye symptoms are often a sign that your current medication regimen is working effectively, not a signal that medications can be reduced or stopped. Reducing systemic immunosuppression without medical guidance can trigger a rebound flare that affects multiple organs, including the eyes. Any changes to your GVHD medications must be made by your transplant team, ideally in consultation with your cornea specialist so that the eye response to any transition can be monitored closely.
Expert Cornea Care for GVHD Patients at Rhode Island Eye Institute
Our fellowship-trained Cornea Specialists at Rhode Island Eye Institute bring together advanced diagnostics, a full range of surgical and non-surgical treatment options, and close coordination with transplant teams to deliver comprehensive care for patients with eye GVHD. From scleral lens fitting and serum drop management to corneal procedures for advanced disease, our team is equipped to support you at every stage of your condition. We understand that managing GVHD is demanding, and we are here to be a consistent, expert partner in protecting your vision for the long term.